share_log

NexImmune | 3: Initial statement of beneficial ownership of securities-Officer Marchio Albert N II

SEC announcement ·  Apr 11 05:18
Summary by Futu AI
Albert N. Marchio II, the Interim Chief Financial Officer of NexImmune, Inc., has filed an Initial Statement of Beneficial Ownership of Securities with the SEC, as per Form 3 requirements. The document, dated April 5, 2024, indicates that Marchio does not beneficially own any securities in the company. The filing, which was signed by attorney-in-fact Jeffrey Cohan on behalf of Marchio on April 10, 2024, is a standard procedure for individuals in key positions within publicly traded companies, as mandated by the Securities Exchange Act of 1934. This filing helps maintain transparency in the market by disclosing the ownership stakes of senior executives and directors.
Albert N. Marchio II, the Interim Chief Financial Officer of NexImmune, Inc., has filed an Initial Statement of Beneficial Ownership of Securities with the SEC, as per Form 3 requirements. The document, dated April 5, 2024, indicates that Marchio does not beneficially own any securities in the company. The filing, which was signed by attorney-in-fact Jeffrey Cohan on behalf of Marchio on April 10, 2024, is a standard procedure for individuals in key positions within publicly traded companies, as mandated by the Securities Exchange Act of 1934. This filing helps maintain transparency in the market by disclosing the ownership stakes of senior executives and directors.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Doc 2

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.